Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Jun;21(6):379-86.
doi: 10.1002/clc.4960210603.

Adjunctive therapy after reperfusion therapy in acute myocardial infarction

D L Dries  1 , A J Solomon, B J Gersh
Affiliations
Review

Adjunctive therapy after reperfusion therapy in acute myocardial infarction

D L Dries et al. Clin Cardiol. 1998 Jun.

Abstract

The current era has witnessed dramatic improvement in the treatment of acute myocardial infarction, due in large part to the more widespread use of thrombolytic therapy aimed at quickly restoring perfusion in the infarct-related artery. This review addresses the role of adjunctive pharmacologic therapy in the thrombolytic era, recognizing that much of the available clinical trial data supporting the role of adjunctive pharmacologic treatment strategies was conducted in patient populations not widely exposed to reperfusion therapy. This review, therefore, explores the data supporting the incremental benefit of therapy with beta blockers, nitrates, angiotensin-converting enzyme inhibitors, or magnesium in addition to thrombolytic therapy. Heparin and aspirin will not be discussed.

PubMed Disclaimer

References

    1. De Vreede JJM, Gorgels ARM, Verstraaten GMP, Vermeer F, Dassen WRM, Wellens HJJ: Did prognosis after acute myocardial infarction change during the past 30 years? A meta‐unalysis. J Am Coll Canlial 1991; 18: 698–706 - PubMed
    1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet 1994; 343: 311–322 - PubMed
    1. Vatner SF, Baig H, Manders WT, Ochs H, Pagani M: Effects of propranalol on regional myocardial function, electrogrums, and blood flow in conscious dogs with myocardial ischemia. J Clin Invest 1977; 60: 353–360 - PMC - PubMed
    1. Mueller HS, Ayres SM, Religa A, Evans RG: Propranalol in the treatment of acute myocardial infarction: Effect on myocardial oxygenation and hemodynamics. Circulation 1974; 49: 1078–1987 - PubMed
    1. Muller HS, Ayres SM: The role of propranalol in the treatment of acute myocardial infarction. Prog Cardiovasc Dis 1977; 19: 405–412 - PubMed

MeSH terms

LinkOut - more resources